European Medicines Agency post-authorisation procedural advice for users of the centralised procedur
This integrated version has been created for printing purposes only. Please refer to the individual question & answers as published in the post-authorisation guidance for access to the hyperlinked information. Questions and answers are being updated continuously, and will be marked by “NEW” or “Rev.” with the relevant date upon publication.
